Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.

Journal of clinical pathology - 1 Nov 2008

Agostinelli C, Piccaluga P P, Went P, Rossi M, Gazzola A, Righi S, Sista T, Campidelli C, Zinzani P L, Falini B, Pileri S A

Abstract excerpt

Peripheral T cell lymphomas (PTCL) account for about 12% of lymphoid tumours worldwide. Almost half show such morphological and molecular variability as to hamper any further classification, and to justify their inclusion in a waste-basket category termed "not otherwise specified (NOS)". The latter term is used for neoplasms with aggressive presentation, poor response to therapy and dismal prognosis. In contrast...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Diagnosis, Differential

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Profiling

Share to Lymphoma, T-Cell, Peripheral

Share to Phenotype

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 18755717
DOI: 10.1136/jcp.2008.055335
PMCID: PMC2582342

Genes

CXCL13

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.PMID 18755717Read ↗

Advances in peripheral T cell lymphomas: pathogenesis, genetic landscapes and emerging therapeutic targetsSemantic proximity Read ↗

The new biology of PTCL‐NOS and AITL: current status and future clinical impactSemantic proximity Read ↗

Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targetsSemantic proximity Read ↗

Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers.Semantic proximity Read ↗

Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?Semantic proximity Read ↗

New insights in the pathogenesis of T-cell lymphomasSemantic proximity Read ↗

Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesisSemantic proximity Read ↗

Pathobiology and molecular profiling of peripheral T-cell lymphomas.Semantic proximity Read ↗

Peripheral T cell lymphomas: from the bench to the clinic.Semantic proximity Read ↗

Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical RealitySemantic proximity Read ↗

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphomaSemantic proximity Read ↗

New insights into the biology of T-cell lymphomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.